Snowden Capital Advisors’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $726K | Sell |
10,260
-372
| -3% | -$27.9K | 0.02% | 642 |
|
|
2025
Q4 | $839K | Sell |
10,632
-267
| -2% | -$21.1K | 0.02% | 599 |
|
|
2025
Q3 | $898K | Sell |
10,899
-1,492
| -12% | -$117K | 0.02% | 561 |
|
|
2025
Q2 | $996K | Buy |
12,391
+1,627
| +15% | +$126K | 0.03% | 521 |
|
|
2025
Q1 | $864K | Sell |
10,764
-897
| -8% | -$74.6K | 0.03% | 560 |
|
|
2024
Q4 | $955K | Sell |
11,661
-145
| -1% | -$12.1K | 0.03% | 519 |
|
|
2024
Q3 | $974K | Sell |
11,806
-634
| -5% | -$47.4K | 0.03% | 526 |
|
|
2024
Q2 | $873K | Sell |
12,440
-37,421
| -75% | -$2.67M | 0.03% | 549 |
|
|
2024
Q1 | $3.7M | Buy |
49,861
+779
| +2% | +$54.3K | 0.12% | 219 |
|
|
2023
Q4 | $3.25M | Sell |
49,082
-1,356
| -3% | -$84.9K | 0.12% | 214 |
|
|
2023
Q3 | $3.17M | Sell |
50,438
-2,468
| -5% | -$154K | 0.13% | 209 |
|
|
2023
Q2 | $2.99M | Buy |
52,906
+10,222
| +24% | +$567K | 0.11% | 232 |
|
|
2023
Q1 | $2.47M | Buy |
42,684
+3,057
| +8% | +$206K | 0.1% | 252 |
|
|
2022
Q4 | $2.87M | Buy |
39,627
+1,552
| +4% | +$111K | 0.12% | 215 |
|
|
2022
Q3 | $2.31M | Sell |
38,075
-130
| -0.3% | -$8.3K | 0.1% | 240 |
|
|
2022
Q2 | $2.4M | Buy |
38,205
+2,317
| +6% | +$153K | 0.11% | 223 |
|
|
2022
Q1 | $2.52M | Buy |
35,888
+7,361
| +26% | +$498K | 0.1% | 231 |
|
|
2021
Q4 | $1.78M | Sell |
28,527
-4,243
| -13% | -$266K | 0.09% | 254 |
|
|
2021
Q3 | $2.02M | Buy |
32,770
+1,028
| +3% | +$61.9K | 0.1% | 252 |
|
|
2021
Q2 | $1.9M | Buy |
31,742
+675
| +2% | +$42.8K | 0.1% | 268 |
|
|
2021
Q1 | $1.89M | Buy |
31,067
+537
| +2% | +$29.6K | 0.11% | 246 |
|
|
2020
Q4 | $1.43M | Buy |
30,530
+55
| +0.2% | +$2.38K | 0.09% | 251 |
|
|
2020
Q3 | $1.13M | Buy |
30,475
+586
| +2% | +$22.2K | 0.09% | 251 |
|
|
2020
Q2 | $1.09M | Buy |
29,889
+869
| +3% | +$30.3K | 0.09% | 250 |
|
|
2020
Q1 | $887K | Buy |
29,020
+6,511
| +29% | +$289K | 0.1% | 258 |
|
|
2019
Q4 | $1.15M | Buy |
22,509
+6,442
| +40% | +$311K | 0.1% | 259 |
|
|
2019
Q3 | $758K | Buy |
16,067
+98
| +0.6% | +$4.67K | 0.08% | 286 |
|
|
2019
Q2 | $793K | Sell |
15,969
-3,084
| -16% | -$145K | 0.08% | 279 |
|
|
2019
Q1 | $811K | Buy |
19,053
+1,324
| +7% | +$58.5K | 0.09% | 274 |
|
|
2018
Q4 | $728K | Buy |
17,729
+3,331
| +23% | +$143K | 0.09% | 267 |
|
|
2018
Q3 | $673K | Buy |
14,398
+4,317
| +43% | +$197K | 0.08% | 288 |
|
|
2018
Q2 | $440K | Buy |
10,081
+276
| +3% | +$12.9K | 0.06% | 320 |
|
|
2018
Q1 | $450K | Buy |
9,805
+300
| +3% | +$14.6K | 0.07% | 284 |
|
|
2017
Q4 | $481K | Sell |
9,505
-2,173
| -19% | -$114K | 0.07% | 283 |
|
|
2017
Q3 | $607K | Sell |
11,678
-1,133
| -9% | -$55.2K | 0.1% | 241 |
|
|
2017
Q2 | $627K | Buy |
12,811
+787
| +7% | +$36.5K | 0.12% | 209 |
|
|
2017
Q1 | $566K | Sell |
12,024
-2,547
| -17% | -$121K | 0.12% | 210 |
|
|
2016
Q4 | $700K | Sell |
14,571
-464
| -3% | -$21.3K | 0.18% | 169 |
|
|
2016
Q3 | $595K | Buy |
+15,035
| New | +$565K | 0.16% | 181 |
|
Other funds holding MET
VCM
VPM
Snowden Capital Advisors's MET Position: Q1 2026 in Review
Snowden Capital Advisors reduced its MetLife (MET) stake by 3.5% in Q1 2026, selling an estimated $27.9K and leaving 10,260 shares worth $726K. The position accounts for 0.02% of the portfolio, ranked #642.
Snowden Capital Advisors first reported a position in MET in Q3 2016 and has held it in 39 quarters since. The position peaked at $3.7M in Q1 2024. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- Snowden Capital Advisors held 10,260 shares of MetLife worth $726K as of Q1 2026.
- Snowden Capital Advisors sold 372 MetLife shares in Q1 2026, an estimated $27.9K.
- MetLife made up 0.02% of Snowden Capital Advisors's portfolio in Q1 2026, its #642 holding.
- Snowden Capital Advisors first reported a position in MetLife in Q3 2016 and has held it in 39 quarters since.
- Snowden Capital Advisors's MetLife position peaked at $3.7M in Q1 2024.
- 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.